Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 18421053

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 Apr 20
First author
Cassidy J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 Oct 1;26(28):4693-4; author reply 4694-5. doi: 10.1200/JCO.2008.18.8060.
    note
    Source null
    related pmid
    18824719
    relationship
    Comment in
  2. citation
    Nat Clin Pract Oncol. 2009 Jan;6(1):10-1. doi: 10.1038/ncponc1261.
    note
    Source null
    related pmid
    18957948
    relationship
    Comment in

Authors and identifiers

  1. name
    Cassidy J
    type
    Author
  2. name
    Clarke S
    type
    Author
  3. name
    Díaz-Rubio E
    type
    Author
  4. name
    Scheithauer W
    type
    Author
  5. name
    Figer A
    type
    Author
  6. name
    Wong R
    type
    Author
  7. name
    Koski S
    type
    Author
  8. name
    Lichinitser M
    type
    Author
  9. name
    Yang TS
    type
    Author
  10. name
    Rivera F
    type
    Author
  11. name
    Couture F
    type
    Author
  12. name
    Sirzén F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cassidy J
    type
    Author
  2. name
    Clarke S
    type
    Author
  3. name
    Díaz-Rubio E
    type
    Author
  4. name
    Scheithauer W
    type
    Author
  5. name
    Figer A
    type
    Author
  6. name
    Wong R
    type
    Author
  7. name
    Koski S
    type
    Author
  8. name
    Lichinitser M
    type
    Author
  9. name
    Yang TS
    type
    Author
  10. name
    Rivera F
    type
    Author
  11. name
    Couture F
    type
    Author
  12. name
    Sirzén F
    type
    Author
bibliography ids
  1. nci-bib-87068606097a3068c85fadfc
book metadata
content sha256
9fd8f352d6e15fc4025bcef6b084d3f92651e7f87f425372b6c9f72fc8c6c917
document type
citation
dois
  1. 10.1200/JCO.2007.14.9898
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:18421053
immutable id
pubmed:18421053@9fd8f352d6e15fc4025bcef6b084d3f92651e7f87f425372b6c9f72fc8c6c917
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
12
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2006-12
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2008 Oct 1;26(28):4693-4; author reply 4694-5. doi: 10.1200/JCO.2008.18.8060.
    note
    Source null
    related pmid
    18824719
    relationship
    Comment in
  2. citation
    Nat Clin Pract Oncol. 2009 Jan;6(1):10-1. doi: 10.1038/ncponc1261.
    note
    Source null
    related pmid
    18957948
    relationship
    Comment in
outcomes validated
false
pmid
18421053
provenance
batch id
e663b4be92ee60a9b059
provider
NCBI PubMed ESummary
record sha256
b4768ff7d4f3e2f678695eb26b34215d3dccd4a3674e40bd6c54b5f40f1ec4bc
response sha256
514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
retrieved at
2026-09-09T23:46:19.265979+00:00
publication date
display
2008 Apr 20
precision
day
year
2008
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/18421053/
title
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice